PAVmed (PAVM) Long-Term Investments (2024 - 2026)

PAVmed has reported Long-Term Investments for 3 years, with the latest figure at $33.5 million in Q2 2026.

• On a quarterly basis, Long-Term Investments fell 6.96% year-over-year to $33.5 million in Q2 2026; TTM through Jun 2026 was $33.5 million, a 6.96% decrease from a year earlier, with the FY2025 full-year figure at $34.1 million, up 33.09% from the prior year.
• Long-Term Investments was $33.5 million for Q2 2026 at PAVmed, down from $34.1 million in the prior quarter.
• The five-year high for Long-Term Investments was $46.6 million in Q1 2025, with the low at $25.6 million in Q4 2024.
• Average Long-Term Investments over 3 years is $34.6 million, with a median of $33.8 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Long-Term Investments jumped 33.09% in 2025, then declined 6.96% in 2026.
• Over 3 years, Long-Term Investments stood at $25.6 million in 2024, then surged by 33.09% to $34.1 million in 2025, then dropped by 1.83% to $33.5 million in 2026.
• The last three Long-Term Investments figures came in at $33.5 million (Q2 2026), $34.1 million (Q4 2025), and $31.6 million (Q3 2025), per Business Quant data.